Cargando…

[(18)F]Fluoromisonidazole PET in rectal cancer

BACKGROUND: There is an increasing interest in developing predictive biomarkers of tissue hypoxia using functional imaging for personalised radiotherapy in patients with rectal cancer that are considered for neoadjuvant chemoradiotherapy (CRT). The study explores [(18)F]fluoromisonidazole ([(18)F]FM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puri, Tanuj, Greenhalgh, Tessa A., Wilson, James M., Franklin, Jamie, Wang, Lia Mun, Strauss, Victoria, Cunningham, Chris, Partridge, Mike, Maughan, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607050/ https://www.ncbi.nlm.nih.gov/pubmed/28933018 http://dx.doi.org/10.1186/s13550-017-0324-x

Ejemplares similares

Imaging of hypoxia in human glioblastoma with dynamic 18F-fluoromisonidazole PET
por: Abdo, Redha-Alla, et al.
Publicado: (2019)

Monitoring vascular normalization induced by antiangiogenic treatment with 18F‐fluoromisonidazole‐PET
por: Hernández-Agudo, Elena, et al.
Publicado: (2015)

(18)F-Fluoromisonidazole in tumor hypoxia imaging
por: Xu, Zuoyu, et al.
Publicado: (2017)

Evaluation of hypoxia in an experimental rat tumour model by [(18)F]Fluoromisonidazole PET and immunohistochemistry
por: Dubois, L, et al.
Publicado: (2004)

Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US
por: Arteaga-Marrero, Natalia, et al.
Publicado: (2015)

A Comparative Study of Noninvasive Hypoxia Imaging with (18)F-Fluoroerythronitroimidazole and (18)F-Fluoromisonidazole PET/CT in Patients with Lung Cancer
por: Wei, Yuchun, et al.
Publicado: (2016)

(18)F-fluoromisonidazole predicts evofosfamide uptake in pancreatic tumor model
por: Grkovski, Milan, et al.
Publicado: (2018)

Kinetic analysis of dynamic (18)F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer
por: Thorwarth, Daniela, et al.
Publicado: (2005)

Erratum to: Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US
por: Arteaga-Marrero, Natalia, et al.
Publicado: (2016)

Quantitative evaluation of oxygen metabolism in the intratumoral hypoxia: (18)F-fluoromisonidazole and (15)O-labelled gases inhalation PET
por: Watabe, Tadashi, et al.
Publicado: (2017)

In vivo evaluation of percutaneous carbon dioxide treatment for improving intratumoral hypoxia using (18)F-fluoromisonidazole PET-CT
por: Maruyama, Koji, et al.
Publicado: (2021)

Assessing Biological Response to Bevacizumab Using 18F-Fluoromisonidazole PET/MR Imaging in a Patient with Recurrent Anaplastic Astrocytoma
por: Barajas, Ramon F., et al.
Publicado: (2015)

Change in (18)F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment
por: Yamaguchi, Shigeru, et al.
Publicado: (2016)

Regional (18)F-fluoromisonidazole PET images generated from multiple advanced MR images using neural networks in glioblastoma
por: Qin, Jianhua, et al.
Publicado: (2022)

Timing of hypoxia PET/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patients
por: Bourigault, Pauline, et al.
Publicado: (2022)

Biological characteristics of intratumoral [F-18]-fluoromisonidazole distribution in a rodent model of glioma
por: HATANO, TOSHIYUKI, et al.
Publicado: (2013)

Reproducibility of (18)F-fluoromisonidazole intratumour distribution in non-small cell lung cancer
por: Grkovski, Milan, et al.
Publicado: (2016)

(18)F‐fluoromisonidazole uptake in advanced stage non‐small cell lung cancer: A voxel‐by‐voxel PET kinetics study
por: McGowan, Daniel R., et al.
Publicado: (2017)

The Roles of Hypoxia Imaging Using (18)F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment
por: Hirata, Kenji, et al.
Publicado: (2019)

Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using (18)F-fluoromisonidazole PET/CT: a pilot study
por: Supiot, Stéphane, et al.
Publicado: (2018)

[(18)F] Sodium Fluoride PET Kinetic Parameters in Bone Imaging
por: Puri, Tanuj, et al.
Publicado: (2021)

A prospective clinical trial of tumor hypoxia imaging with (18)F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy
por: Tachibana, Izumi, et al.
Publicado: (2013)

[18F]FDG PET/MRI in rectal cancer
por: Crimì, Filippo, et al.
Publicado: (2021)

Whole tumor kinetics analysis of (18)F-fluoromisonidazole dynamic PET scans of non-small cell lung cancer patients, and correlations with perfusion CT blood flow
por: McGowan, Daniel R., et al.
Publicado: (2018)

Evaluation of isocitrate dehydrogenase mutation in 2021 world health organization classification grade 3 and 4 glioma adult-type diffuse gliomas with 18F-fluoromisonidazole PET
por: Wang, Yang, et al.
Publicado: (2023)

A Short Dynamic Scan Method of Measuring Bone Metabolic Flux Using [(18)F]NaF PET
por: Puri, Tanuj, et al.
Publicado: (2021)

Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer; methodological issues to avoid mismanagement of the patients
por: Sabour, Siamak
Publicado: (2017)

[(18)F] fluoromisonidazole and [(18)F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study
por: Gagel, Bernd, et al.
Publicado: (2006)

Evaluation of changes in the tumor microenvironment after sorafenib therapy by sequential histology and (18)F-fluoromisonidazole hypoxia imaging in renal cell carcinoma
por: MURAKAMI, MASAHIRO, et al.
Publicado: (2012)

Intracellular hypoxia measured by (18)F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancer
por: Asano, Aya, et al.
Publicado: (2018)

The role of necrosis, acute hypoxia and chronic hypoxia in (18)F-FMISO PET image contrast: a computational modelling study
por: Warren, Daniel R, et al.
Publicado: (2016)

Multiparametric [(18)F]Fluorodeoxyglucose/ [(18)F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study
por: Pinker, Katja, et al.
Publicado: (2016)

Correlation of Tumor Hypoxia Metrics Derived from (18)F-Fluoromisonidazole Positron Emission Tomography and Pimonidazole Fluorescence Images of Optically Cleared Brain Tissue
por: Scarpelli, Matthew L., et al.
Publicado: (2020)

Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer
por: Rendl, Gundula, et al.
Publicado: (2014)

Evaluating cardiac hypoxia in hibernating myocardium: Comparison of (99m)Tc-MIBI/(18)F-fluorodeoxyglucose and (18)F-fluoromisonidazole positron emission tomography-computed tomography in relation to normal, hibernating, and infarct myocardium
por: Jagtap, Rajlaxmi, et al.
Publicado: (2019)

Cutaneous Metastase of Rectal Neuroendocrine Carcinoma Revealed on (18)F-FDG PET/CT
por: Şahin, Ömer Faruk, et al.
Publicado: (2023)

Predictive Value of [(18)F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer
por: Kim, Sung Hoon, et al.
Publicado: (2019)

Rectal Carcinoma Metastases to Multiple Skeletal Muscles-Role of F-18 FDG PET/CT
por: Prabhu, Meghana, et al.
Publicado: (2017)

18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy
por: Capelli, Giulia, et al.
Publicado: (2022)

Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693)
por: Asano, Aya, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1uf9u2kvgufmdo3ndgbenoapn6